Please listen as Drs. Pradeep, Blankenstein, and Nasir discuss the changes in 2018 cholesterol guidelines specifically as they pertain to the focus specifically on the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in these new guidelines, and shift that changed from targeting predominantly LDL targets to focusing instead on making decisions based on absolute risk.